- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alivus Life Sciences reported record quarterly revenues of Rs 672.9 Cr and highest-ever 36.4% EBITDA margins. Performance was driven by CDMO recovery, new product launches, and efficiency. The company is net debt-free, with Rs 733.0 Cr cash, and expanding R&D and manufacturing capacity.